Regulatory Perspectives on Qualification of Biomarkers for Drug Development

Time: 11:00 am
day: Day Two


  • Understanding the different ways biomarkers can be utilized in drug development
  • Recognizing the different pathways that a biomarker can be qualified for use in drug development
  • Facilitating collaboration between researchers, industry, and patient advocacy groups to enable development of biomarkers to address areas of unmet need